Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma

Total cell-free DNA (cfDNA) and tumor-derived cfDNA (ctDNA) can be used to study tumor-derived genetic aberrations. We analyzed the diagnostic and prognostic potential of cfDNA and ctDNA, obtained from pediatric patients with rhabdomyosarcoma. METHODS: cfDNA was isolated from diagnostic plasma sampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lak, Nathalie S.M., van Zogchel, Lieke M.J., Zappeij-Kannegieter, Lily, Javadi, Ahmad, van Paemel, Ruben, Vandeputte, Charlotte, De Preter, Katleen, De Wilde, Bram, Chicard, Mathieu, Iddir, Yasmine, Schleiermacher, Gudrun, Ruhen, Olivia, Shipley, Janet, Fiocco, Marta, Merks, Johannes H.M., van Noesel, Max M., van der Schoot, C. Ellen, Tytgat, Godelieve A.M., Stutterheim, Janine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928631/
https://www.ncbi.nlm.nih.gov/pubmed/36652664
http://dx.doi.org/10.1200/PO.22.00113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928631/
https://www.ncbi.nlm.nih.gov/pubmed/36652664
http://dx.doi.org/10.1200/PO.22.00113

Ejemplares similares